Pyros Pharmaceuticals

New York, United States

Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics.

$450K raised

Apr 2022

Seed

Biotechnology Health Care Medical Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pyros Pharmaceuticals

How much funding has Pyros Pharmaceuticals raised?

Pyros Pharmaceuticals has raised $450K in total funding. The most recent round was Seed. The last funding was announced in April 2022.

Where is Pyros Pharmaceuticals headquartered?

Pyros Pharmaceuticals is headquartered in New York, United States.

What does Pyros Pharmaceuticals do?

Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics.

What stage is Pyros Pharmaceuticals at?

Pyros Pharmaceuticals is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 4, 2022.

MLA

"Pyros Pharmaceuticals — Funding & Investors." VCBacked, April 4, 2022, https://www.vcbacked.co/company/pyros-pharmaceuticals. Accessed July 3, 2026.

APA

VCBacked. (2022). Pyros Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/pyros-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Pyros Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/pyros-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 4, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K